14 mrt ,2018

Ardena Group acquires ChemConnection

We are pleased to announce that ChemConnection has become part of the Ardena Group.  Joining Ardena enables us to become your one source contractor for all chemical, pharmaceutical and (bio)analytical needs that arise in the clinical supply chain. We believe that by joining forces, substantial benefits will be created, reducing your project risks and shortening […]

READ MORE
07 dec ,2017

Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials. Click here for press release.

READ MORE

Older news

13 okt ,2017

BSc/MSc organic synthesis

We are looking for A synthetic organic chemist (BSc or MSc) to strengthen our process R&D team for small molecules. In this position you will: independently and in teams work on process R&D for API’s; interact with colleague in analytics, manufacture, and QA for the execution of projects; writing of technical reports in English; develop […]

Further reading >
13 okt ,2017

BSc/MSc nano medicines R&D

We are looking for A synthetic organic chemist (BSc or MSc) to strengthen our process R&D team for nanomedicines. In this position you will: independently and in teams work on process R&D for nanomedicines; interact with colleague in analytics, manufacture, and QA for the execution of projects; writing of technical reports in English; develop scientific, […]

Further reading >
24 apr ,2017

PhD organic synthesis

About ChemConnection ChemConnection is a young, dynamic, and very innovative pharmaceutical company. As a CDMO (custom development and manufacturing organization) we support other pharmaceutical companies with the development of their new products. ChemConnection is specialized in process and analytical development and cGMP manufacture of Active Pharmaceutical Ingredients (API) and nanomedicines. ChemConnection has a globally leading […]

Further reading >
06 sep ,2016

Austin Chemical Company, Syncom, and ChemConnection announce partnership and establish joint venture SynConnection LLC

BUFFALO GROVE (IL, USA), GRONINGEN (The Netherlands), OSS (The Netherlands), 6 September 2016 – Austin Chemical Company Inc, a pharmaceutical procurement and logistics service provider announced today the joint venture with Syncom BV, a pharmaceutical contract synthesis company, and ChemConnection BV, a GMP licensed contact manufacturing company. The development of novel active pharmaceutical ingredients (NCEs, […]

Further reading >
16 jun ,2016

CHEMCONNECTION AND CRISTAL THERAPEUTICS ANNOUNCE SUCCESSFUL GMP PRODUCTION OF CRIPEC® DOCETAXEL FOR PHASE 1/2A CLINICAL TRIALS

Oss and Maastricht, The Netherlands, June 1, 2016 – ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences company developing nanomedicines against cancer and other diseases. “ChemConnection has made a tremendous leap forward in becoming the […]

Further reading >
26 jan ,2016

Renewal GMP license

January 21, ChemConnection was audited by the Dutch health authorities (IGZ). The audit was very successful and has resulted in the renewal of the GMP manufacturing license for API and bulk drug product. With the licenses in place, ChemConnection continues its leading role in nanomedicine development and manufacturing

Further reading >
12 nov ,2015

ChemConnection is hiring

ChemConnection has a job vacancy for an early stage researcher (PhD candidate) for the NANOMED European Training Network. The application deadline is November 23, 2015. Please download the job description for a detailed overview of this vacancy.

Further reading >
07 okt ,2015

ChemConnection present at BioEurope 2015

ChemConnection will be present at the autumn edition of BioEurope in Munich, November 2015. Please contact us via the partnering network, or send us an email message to organize an appointment. ChemConnection will be represented by our scientific advisor nanomedicines Dr. Marcel van der Sluis.

Further reading >
Menu
class="last-menu-item menu-itemve-menu" class="">
  • Drug Substances
  • Nanomedicines
  • Analytical Sciences
  • About us
  • Contact